Skye Bioscience, Inc.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Skye Bioscience, Inc. now
Current reporting with the operating signal separated from the noise.
Shareholders that lost money on Skye Bioscience, Inc.(SKYE) should contact Levi & Korsinsky about pending Class Action
Investors are testing whether Skye Bioscience, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit | Morningstar
The story matters when it changes Skye Bioscience, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.SKYE Class Action Reminder: Skye Bioscience, Inc. Stockholders Should Contact Robbins LLP for Information About the Securities Class Action Lawsuit
Investors are testing whether Skye Bioscience, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Skye Bioscience, Inc. Sued for Securities Law Violations
The story matters when it changes Skye Bioscience, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Skye Bioscience, Inc. (SKYE) Q3 2025 Earnings Call Transcript
Investors are testing whether Skye Bioscience, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Skye Bioscience, Inc. (SKYE) Q4 2024 Earnings Call Transcript
Investors are testing whether Skye Bioscience, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Is Skye Bioscience, Inc. (SKYE) the Best Russell 2000 Stock to Buy According to Analysts?
Investors are testing whether Skye Bioscience, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.SKYE Investors Have Opportunity to Join Skye Bioscience, Inc. Fraud Investigation with the Schall Law Firm
The story matters when it changes Skye Bioscience, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Latest SKYE filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
Skye Bioscience, Inc., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →